Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application
- PMID: 24319468
- PMCID: PMC3844279
- DOI: 10.1155/2013/789814
Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application
Abstract
The gut mucosa undergoes continuous antigenic exposure from food antigens, commensal flora derived ligands, and pathogens. This constant stimulation results in controlled inflammatory responses that are effectively suppressed by multiple factors. This tight regulation, necessary to maintain intestinal homeostasis, is affected during inflammatory bowel diseases (IBD) resulting in altered immune responses to harmless microorganisms. Dendritic cells (DCs) are sentinels of immunity, located in peripheral and lymphoid tissues, which are essential for homeostasis of T cell-dependent immune responses. The expression of a particular set of pathogen recognition receptors allows DCs to initiate immune responses. However, in the absence of danger signals, different DC subsets can induce active tolerance by inducing regulatory T cells (Treg), inhibiting inflammatory T helper cell responses, or both. Interestingly, several protocols to generate clinical grade tolerogenic DC (tol-DCs) in vitro have been described, opening the possibility to restore the intestinal homeostasis to bacterial flora by cellular therapy. In this review, we discuss different DC subsets and their role in IBD. Additionally, we will review preclinical studies performed in animal models while describing recent characterization of tol-DCs from Crohn's disease patients for clinical application.
Figures


Similar articles
-
Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.Front Immunol. 2018 May 31;9:1169. doi: 10.3389/fimmu.2018.01169. eCollection 2018. Front Immunol. 2018. PMID: 29904379 Free PMC article. Review.
-
Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.World J Gastroenterol. 2011 Sep 7;17(33):3761-75. doi: 10.3748/wjg.v17.i33.3761. World J Gastroenterol. 2011. PMID: 21987618 Free PMC article. Review.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.Am J Gastroenterol. 2001 Oct;96(10):2946-56. doi: 10.1111/j.1572-0241.2001.04686.x. Am J Gastroenterol. 2001. PMID: 11693331
-
Intestinal dendritic cells: their role in intestinal inflammation, manipulation by the gut microbiota and differences between mice and men.Immunol Lett. 2013 Feb;150(1-2):30-40. doi: 10.1016/j.imlet.2013.01.007. Epub 2013 Jan 23. Immunol Lett. 2013. PMID: 23352670 Review.
Cited by
-
Deinococcus radiodurans R1 Lysate Induces Tolerogenic Maturation in Lipopolysaccharide-Stimulated Dendritic Cells and Protects Dextran Sulfate Sodium-Induced Colitis in Mice.J Microbiol Biotechnol. 2022 Jul 28;32(7):835-843. doi: 10.4014/jmb.2203.03008. Epub 2022 Jun 7. J Microbiol Biotechnol. 2022. PMID: 35719091 Free PMC article.
-
Alterations in Intestinal Antioxidant and Immune Function and Cecal Microbiota of Laying Hens Fed on Coated Sodium Butyrate Supplemented Diets.Animals (Basel). 2022 Feb 22;12(5):545. doi: 10.3390/ani12050545. Animals (Basel). 2022. PMID: 35268114 Free PMC article.
-
Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.Front Immunol. 2017 Nov 20;8:1514. doi: 10.3389/fimmu.2017.01514. eCollection 2017. Front Immunol. 2017. PMID: 29250057 Free PMC article. Review.
-
Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?World J Stem Cells. 2015 Mar 26;7(2):343-51. doi: 10.4252/wjsc.v7.i2.343. World J Stem Cells. 2015. PMID: 25815119 Free PMC article. Review.
-
Intestinal dendritic cells change in number in fulminant hepatic failure.World J Gastroenterol. 2015 Apr 28;21(16):4883-93. doi: 10.3748/wjg.v21.i16.4883. World J Gastroenterol. 2015. PMID: 25945001 Free PMC article.
References
-
- Hart AL, Al-Hassi HO, Rigby RJ, et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology. 2005;129(1):50–65. - PubMed
-
- Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nature Medicine. 2004;10(5):475–480. - PubMed
-
- Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449(7161):419–426. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources